RATIONALE: Allergen-specific memory T cells play a vital role in both IgE-and non-IgE mediated food hypersensitivity. Identifying and analyzing allergen-specific TCRs in affected patients may provide useful targets for therapeutics and diagnostics. METHODS: PBMCs from peanut-allergic and milk-allergic eosinophilic esophagitis patients were stimulated with peanut and milk protein, respectively. Activated and resting CD4+ memory T cells were sorted based on the expression of CD40L (CD154) and gDNA was used for TCRbseq to obtain CDR3 sequences from both compartments. An analysis pipeline was developed to select putatively-specific CDR3 sequences (psCDR3s) that were significantly enriched in CD154+ versus CD154-cells using a G-test of independence with FDR q < 0.05. The CDR3 antigen-contact residues were further evaluated for motifs, 3-5 amino acids in length, and analyzed for association with antigen-specificity. RESULTS: 6292 (14.1%) peanut-psCDR3s and 1080 (4.26%) milkpsCDR3s were enriched within the total CD154+ pool. Consistent with antigen-selection, psCDR3s were more homologous, as measured by hamming distance (p < 0.01). The vast majority of psCDR3s are private, however, 23 motifs in milk-and 63 in peanut-psCDR3s were public, highly-enriched in activated cells (q < 0.05, 10-fold higher in enriched) and found in > _ 3 unique CDR3s, implicating them to be common epitopespecific sequences. CONCLUSIONS: A small subset of CD154+ clones share sequence homology and are most likely to represent true antigen-specific T cells. Identification of these clones and their homologous sequences in the CDR3 contact residues may be used for improved diagnostics and therapeutics in both IgE-and non-IgE-mediated allergic diseases. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. RATIONALE: Peanut-allergic patients who only have transient desensitization (TD) after oral immunotherapy (OIT) are known to generally have higher levels of allergen-specific IgE before starting OIT. We hypothesize that the IgE hi endophenotype is characterized by pre-existing B cell memory that predisposes the post-immunotherapy antibody repertoire to be less protective. METHODS: Peanut-allergic children, aged 7-13, enrolled in a singlecenter, open-label peanut OIT trial. After 1 year of OIT, 23 subjects with challenge-proven desensitization (post-OIT) underwent challenge after 1 month of avoidance (post-avoidance). TD was confirmed in 13 patients and sustained unresponsiveness (SU) in 9. Using a fluorescent Arah2 multimer, we isolated Arah2-specific B cells for single-cell immunoglobulin sequencing and recombinant antibody production. We isolated memory B cells (CD19 + CD27 + ) cells by flow cytometry for heavy chain immunoglobulin deep sequencing. We analyzed the repertoires using R/ Bioconductor and the Immcantation framework. Affinity was measured by biolayer interferometry. RESULTS: TD subjects had higher Arah2-specific IgE levels before OIT (p50.002). In the subset with high serum Arah2 IgE levels, their Ara h 2 IgG repertoire was more diverse (p<0.05), had high affinity for Arah2 in the subnanomolar range, and had increased homology with the memory B cell IgE repertoire as opposed to the IgA repertoire in SU patients. RATIONALE: Food allergy (FA) affects 8% of US children. A comprehensive understanding of parental history of FA, and atopy more broadly, may provide insight into underlying heritable mechanisms contributing to the incidence of FA. We hypothesize that having a parental history of atopy and FA will impact FA development. METHODS: A survey was administered via web and telephone to a sample of US households between 2015-2016, providing parent-proxy responses for 41,341 children. Stringent symptom criteria were developed with FA experts to distinguish respondents with ''convincing'' FA from those with similar conditions. Post stratification-weighted proportions were estimated to compare FA characteristics and observe family history. RESULTS: Children were more likely to develop FA if there was a parental history of asthma (15.2% vs. 7.6%; p<.05), eczema (13.7% vs. 7.6%; p<.05), or seasonal allergy (11.8% vs. 7.6%; p<.05). This was most pronounced in children with a parent with FA (22.9% vs. 7.6%; p<.05). When this was analyzed using multiple logistic regression analysis, children with parental history FA were 5.92 (95% CI: 5.04-6.81, p<.05) times more likely to develop FA. Children were more likely to develop food allergies if their parents had two or more atopic conditions (17.5% vs. 7.6% (p<.05) and three or more atopic conditions (26.1 vs. 7.6% p<.05). CONCLUSIONS: Children were more likely to develop food allergies as the number of atopic conditions for parents increased, especially in those who had a parental history of FA. Parental history of atopy is a risk factor that may play a significant role in FA development.
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